We are live on ! Find out more
GDRX icon

GoodRx Holdings

216 hedge funds and large institutions have $4.99B invested in GoodRx Holdings in 2021 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 63 increasing their positions, 61 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.25% more ownership

Funds ownership: 185.06%189.31% (+4.3%)

3% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 61

0% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 54

1% less funds holding

Funds holding: 218216 (-2)

13% less capital invested

Capital invested by funds: $5.73B → $4.99B (-$737M)

16% less call options, than puts

Call options by funds: $58.4M | Put options by funds: $69.5M

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

Holders
216
Holders Change
-2
Holders Change %
-0.92%
% of All Funds
3.32%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
54
Increased
63
Reduced
61
Closed
54
Calls
$58.4M
Puts
$69.5M
Net Calls
-$11.1M
Net Calls Change
+$16.3M
Name Holding Trade Value Shares
Change
Change in
Stake
FPM
1
Francisco Partners Management
California
$2.77B
Morgan Stanley
2
Morgan Stanley
New York
$421M +$329M +8,184,111 +174%
ACA
3
Abdiel Capital Advisors
New York
$263M +$324M +8,062,788 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$198M +$21.2M +526,719 +10%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$126M -$55.8M -1,386,695 -26%
SLG
6
Silver Lake Group
California
$115M
Tiger Global Management
7
Tiger Global Management
New York
$76.6M
Goldman Sachs
8
Goldman Sachs
New York
$63.4M +$28.7M +714,306 +58%
CG
9
Carmignac Gestion
France
$59.7M +$1.89M +47,028 +3%
TCMX
10
Technology Crossover Management X
California
$54M
DPCM
11
Darlington Partners Capital Management
California
$52.3M +$64.4M +1,599,629 New
LSCM
12
Light Street Capital Management
California
$46.5M -$23.9M -592,930 -29%
ZCI
13
Zevenbergen Capital Investments
Washington
$42.6M -$1.42M -35,215 -3%
DIG
14
Dragoneer Investment Group
California
$42.5M
Marshall Wace
15
Marshall Wace
United Kingdom
$35.6M +$4.12M +102,426 +10%
BlackRock
16
BlackRock
New York
$34.3M -$470K -11,682 -1%
LOAMS
17
Lombard Odier Asset Management (Switzerland)
Switzerland
$30M -$3.69M -91,628 -9%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$28.8M -$42.1M -1,045,552 -54%
RRCP
19
Rip Road Capital Partners
Massachusetts
$27.8M +$3.48M +86,600 +11%
IC
20
Iconiq Capital
California
$26.1M +$1.09M +27,000 +3%
PTC
21
Petrus Trust Company
Texas
$25.6M +$107K +2,659 +0.3%
Fidelity International
22
Fidelity International
Bermuda
$23.4M +$9.5M +236,148 +49%
Norges Bank
23
Norges Bank
Norway
$23M +$28.4M +705,300 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$20.7M +$796K +19,795 +3%
CIBC Private Wealth Group
25
CIBC Private Wealth Group
Georgia
$18.2M +$8.49M +211,090 +61%

GDRX Hedge Fund Activity: Q4 2021 in Review

216 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2021, worth a combined $4.99B — down 13% from $5.73B a quarter earlier.

Fund positioning in GDRX was balanced in Q4 2021: 54 funds opened new positions, 54 closed out, 63 added to existing stakes and 61 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $329M. The largest seller was Atreides Management, exiting entirely with an estimated $94.9M sold.

  • 216 institutional investors held GoodRx Holdings (GDRX) as of Q4 2021, down from 218 in Q3 2021.
  • Funds reported $4.99B of GoodRx Holdings stock for Q4 2021, down 13% quarter-over-quarter.
  • 54 funds opened new GoodRx Holdings positions in Q4 2021 and 54 closed out, a net change of 0 holders.
  • The largest GoodRx Holdings buyer in Q4 2021 was Morgan Stanley, an estimated $329M added.
  • The largest GoodRx Holdings seller in Q4 2021 was Atreides Management, an estimated $94.9M sold.

Based on aggregated 13F filings for Q4 2021.